Paclitaxel Varifarma

PDFPrintEmail

PACLITAXEL VARIFARMA
Description
 
Product Name : PACLITAXEL VARIFARMA

Generic Name : Antimicrotubule agent, Cytotxic

Strength : 30 mg 

Packing : 5ml

Indications :Breast cancer, Ovarian Cancer, Head and neck Cancer, Non-Small Cell Lung Cancer Drug Interaction: Doxorubicin, Epirubicin, Gemcitabine, Cisplatin, Carboplatin, Warfarin, Transtuzumab.

Dosage Guidelines :intravenous:q W3 175mg / m2 over 3 hours

Premedication: To minimize severe hypersensitivity reactions, patients should be premedicated with dexamethasone 20 mg p.o 12 and 6 hours before (consider using 10 mg for HIV patients) diphenhydramine 50 mg IV 30-60 minutes before, and cimetidine 300mg IV or ranitidine 50mg IV 30-60 minutes before.

Single agent weekly paclitaxel is safe and effective as neoadjuvant chemotherapy in patients with LOBC and LABC with modest pathologic responses.
 
 

 

Featured Products